Results 201 to 210 of about 192,543 (284)
An increase in the urinary levels of prostaglandin D<sub>2</sub> and platelet-activating factor metabolites in dogs with mast cell tumor. [PDF]
Yamazaki A +8 more
europepmc +1 more source
Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy
Lactate, once deemed a metabolic waste, emerges as a central regulator of cancer progression. This review elucidates how lactate and its epigenetic derivative, protein lactylation, orchestrate tumor metabolism, immune suppression, and therapeutic resistance.
Jiajing Gong +5 more
wiley +1 more source
Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors. [PDF]
Dahal A +12 more
europepmc +1 more source
Platelet-activating factor: a phospholipid autacoid with diverse actions
ME Venable +3 more
doaj +1 more source
This study established an RT‐MSCs‐based therapeutic approach for scleroderma in mice. RT‐MSCs attenuated fibrosis by regulating mitochondrial autophagy and restored gut microbiota homeostasis. Metabolomic analyses confirmed recovery of key metabolites, and RT‐MSCs demonstrated favorable lesion targeting and safety profiles.
Xue Xia +5 more
wiley +1 more source
HSP90α is significantly upregulated in platelets from sepsis patients, with its origin from megakaryocyte‐derived trafficking. Furthermore, activated platelets secrete HSP90α into the extracellular space in both free and exosome‐associated forms. Finally, extracellular HSP90α directly engages TLR4 on neutrophils to induce autophagy, leading to NET ...
Chengbo Wang +17 more
wiley +1 more source
An immune-adrenergic pathway induces lethal levels of platelet-activating factor in mice. [PDF]
Tanaka S +14 more
europepmc +1 more source

